Precision BioScience snags $110 mln Series B

Durham, North Carolina-based Precision BioScience, a genome editing system provider, has raised $110 million in Series B financing. ArrowMark Partners led the round with participation from other investors that included Franklin Templeton Investments, Cowen Healthcare Investments, Brace Pharma Capital, Adage Capital Management, Cormorant Asset Management, Gilead Sciences, Vivo Capital, Alexandria Venture Investments, Ridgeback Capital, Agent Capital, Leerink Partners, venBio, F-Prime and Osage University Partners.

Source: Press Release